AVTRAvantor, Inc.
$17.29+19% 1Y
$17.29
$7.4152 weeks$17.29
Latest close: a new 52-week highOct 23, 2026what changed →
The financials
Avantor, Inc. by the numbers
Avantor, Inc. (AVTR) reported revenue of $1.69B in Q2 2026 (quarter ended Jun 30, 2026), up 0.5% from the same quarter a year earlier. That came with a gross margin of 32% and net income of $38M (2.3% of revenue). For the full year FY2025, revenue was $6.55B (−3.4% year on year) and net income −$530M. Its largest segment in Q2 2026 was VWR Distribution Services at $1.24B, 73% of the disclosed total, well ahead of Bioscience Medtech Products at 27%. The next results filing is expected around Oct 28, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $1.69B | $1.68B | +0.5% |
| Gross profit | $537M | $554M | −3.1% |
| Operating income | $122M | $129M | −5.4% |
| Net income | $38M | $65M | −41% |
| Diluted EPS | $0.06 | $0.09 | −33% |
| Operating | Revenue | Share |
|---|---|---|
| VWR Distribution Services | $1.24B | 73% |
| Bioscience Medtech Products | $452M | 27% |
Business segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Jun 2026Total $1.69B (+7.0%)
VWR Distribution Services grew +2.7% year on yearBioscience Medtech Products -5.1% year on year
Segment Latestquarter on quarteryear on year
- VWR Distribution Services$1.24B$1.24Bquarter on quarter +7.9%year on year +2.7%+7.9%+2.7%
- Bioscience Medtech Products$451.8M$451.8Mquarter on quarter +4.7%year on year -5.1%+4.7%-5.1%
Medical Instruments & Supplies
Ranks #12 of 20 by RyuScore